Arabian Journal of Chemistry ( IF 5.3 ) Pub Date : 2022-09-29 , DOI: 10.1016/j.arabjc.2022.104313 Huimin Zhu , Wanbo Zeng , Tangna Zhao , Weiguo Shi , Xiao Dong , Aiping Zhang , Xiang Li , Liang Xu
Fatigue has a negative influence on daily life and work, and serious or chronic fatigue can even cause health problems. Studies have shown that 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) can exert anti-fatigue effects by activating AMP-activated protein kinase (AMPK). In this study, six AICAR derivatives with substitution at the hydroxyl sites of the ribose moiety were synthesized and evaluated as anti-fatigue agents. All of the derivatives were demonstrated to effectively resist fatigue in animal models. The mice treated with the optimal compound ZHM-01 showed an 8.6-fold greater exhaustion distance in the running wheel test and a 5.1-fold greater exhaustion time in the weight-loaded swimming test than those of the blank control group. ZHM-01 treatment also reduced lactic acid (LA) and blood urea nitrogen (BUN) accumulation during exercise. In addition, ZHM-01 administration enhanced the phosphorylation of AMPK but did not excite the central nervous system. Moreover, ZHM-01 showed good biological safety in a 21-day toxicity evaluation. This study provides a new reference for the development of treatments for fatigue-related health problems.
中文翻译:
![](https://scdn.x-mol.com/jcss/images/paperTranslation.png)
5-氨基咪唑-4-甲酰胺核苷衍生物抗疲劳剂的合成与评价
疲劳对日常生活和工作产生负面影响,严重或慢性疲劳甚至会导致健康问题。研究表明,5-氨基咪唑-4-羧酰胺-1-β-D-呋喃核糖苷(AICAR)可通过激活AMP活化蛋白激酶(AMPK)发挥抗疲劳作用。在这项研究中,合成了六种在核糖部分的羟基位点具有取代的 AICAR 衍生物,并作为抗疲劳剂进行了评估。在动物模型中,所有衍生物均被证明可有效抵抗疲劳。与空白对照组相比,经最佳化合物ZHM-01处理的小鼠在跑轮试验中的力竭距离延长了8.6倍,在负重游泳试验中的力竭时间延长了5.1倍。ZHM-01治疗还减少了运动期间乳酸(LA)和血尿素氮(BUN)的积累。此外,ZHM-01给药增强了 AMPK 的磷酸化,但不刺激中枢神经系统。此外,ZHM-01在为期 21 天的毒性评估中表现出良好的生物安全性。该研究为开发与疲劳相关的健康问题的治疗方法提供了新的参考。